Kolexia
Yazdanpanah Yazdan
Gastro-entérologie
Hôpital Bichat-Claude-Bernard
Paris, France
621 Activités
1.1 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Maladies transmissibles Hépatite C Hépatite Tuberculose Infections à coronavirus Maladies virales Hépatite C chronique

Industries

MSD
3 collaboration(s)
Dernière en 2022
LIVE ! BY GL EVENTS
1 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Enterococcal endocarditis management and relapses.
JAC-antimicrobial resistance   06 mars 2024
Updates in HIV infection therapeutics.
La Revue du praticien   29 février 2024
Dataids_PEC: Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Essai Clinique (DatAids)   26 février 2024
Dat'Aids Prevention: HIV Prevention in France : "Dat'AIDS Prevention"
Essai Clinique (DatAids)   26 février 2024
CAPELLA: A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS-6207 in Combination With an Optimized Background Regimen in Heavily Treatment Experienced People Living With HIV-1 Infection With Multidrug Resistance
Essai Clinique (Gilead)   23 février 2024
A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects: A Phase IIb Study Evaluating a Long-Acting Intramuscular Regimen of GSK1265744 Plus TMC278 For The Maintenance of Virologic Suppression Following an Induction of Virologic Suppression on an Oral Regimen of GSK1265744 Plus Abacavir/Lamivudine in HIV-1 Infected, Antiretroviral Therapy-Naive Adult Subjects
Essai Clinique (ViiV Healthcare)   20 février 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy: 96-week pooled analysis.
AIDS (London, England)   12 février 2024
Trans&VIH: National Survey About Trajectory and Life Conditions of HIV Trans People in France
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   09 février 2024
Mpox: The alarm went off. Have we gone back to sleep?
PLoS neglected tropical diseases   18 janvier 2024